Increasing public acceptance of generic drugs has slowed the overall U.S. spending on drugs despite an aging population and introduction of expensive new drugs. Analysts expect the next five years to be the golden era for generic drugs, with many generics coming on the market to compete with brand-name drugs losing their patent protection.

Full Story:

Related Summaries